info@synchemia.com | sales@synchemia.com 
9766925136 
Recent Products
Oxybutynin-N-Subsituted Allyl Impurity
| CAT No | : SRC-O15009 |
| CAS No | : NA |
| Mol. F | : C38H49NO6 |
| Mol. Wt | : 615.8 g/mol |
| INV STATUS | : In Stock |
Edoxaban Desmethyl Impurity
| CAT No | : SRC-E5004 |
| CAS No | : 778571-11-2 |
| Mol. F | : C23H28ClN7O4S |
| Mol. Wt | : 534 g/mol |
| INV STATUS | : In Stock |
Edoxaban Dipyridine Impurity
| CAT No | : SRC-E5005 |
| CAS No | : 2568974-02-5 |
| Mol. F | : C23H25Cl2N7O5 |
| Mol. Wt | : 550.4g/mol |
| INV STATUS | : In Stock |
Linagliptin N,N’-Methylene Dimer
.png)
| CAT No | : SRC-L12031 |
| CAS No | : 2489212-72-6 |
| Mol. F | : C51H56N16O4 |
| Mol. Wt | : 957.1 g/mol |
| INV STATUS | : In Stock |
Sacubitril Impurity 19
| CAT No | : SRC-S19014 |
| CAS No | : 2459446-54-7 |
| Mol. F | : C22H23NO4 |
| Mol. Wt | : 365.4 |
| INV STATUS | : In Stock |
Orlistat USP Related Compound D
| CAT No | : SRC-O15035 |
| CAS No | : 130793-27-0 |
| Mol. F | : C29H53NO5 |
| Mol. Wt | : 495.7 g/mol |
| INV STATUS | : In Stock |
Fluvoxamine Z-Isomer
| CAT No | : SRC-F6004 |
| CAS No | : 89035-92-7 |
| Mol. F | : C15H21F3N2O2 |
| Mol. Wt | : 318.3 |
| INV STATUS | : In Stock |
PBT CYCLIC DIMER or Cyclobis(1,4-butylene terephthalate)
| CAT No | : SRC-P16101 |
| CAS No | : 63440-93-7 |
| Mol. F | : C24H24O8 |
| Mol. Wt | : 440.45g/mol |
| INV STATUS | : In Stock |
PBT CYCLIC TRIMER or Cyclotris(1,4-butylene Terephthalate)
.png)
| CAT No | : SRC-P16102 |
| CAS No | : 63440-94-8 |
| Mol. F | : C36H36O12 |
| Mol. Wt | : 660.67g/mol |
| INV STATUS | : In Stock |
PBT CYCLIC TETRAMER or Cyclotetrakis(1,4-butylene Terephthalate)
| CAT No | : SRC-P16103 |
| CAS No | : 29278-72-6 |
| Mol. F | : C48H48O16 |
| Mol. Wt | : 880.9g/mol |
| INV STATUS | : In Stock |
PBT CYCLIC PENTAMER or Cyclopentakis(1,4-butyleneTerephthalate)
| CAT No | : NA |
| CAS No | : 82298-33-7 |
| Mol. F | : C60H60O20 |
| Mol. Wt | : 1101.11 g/mol |
| INV STATUS | : In Stock |
Pretomanid Impurity 2
| CAT No | : SRC-P16162 |
| CAS No | : 2756820-12-7 |
| Mol. F | : C19H21BrF3N3O6 |
| Mol. Wt | : 524.3 |
| INV STATUS | : In Stock |
Pretomanid Dimer Impurity
| CAT No | : SRC-P16163 |
| CAS No | : NA |
| Mol. F | : C21H19F3N6O9 |
| Mol. Wt | : 556.4 |
| INV STATUS | : In Stock |
Pretomanid Impurity 7
| CAT No | : SRC-P16169 |
| CAS No | : 2512206-85-6 |
| Mol. F | : C15H16F3N3O6 |
| Mol. Wt | : 391.3 |
| INV STATUS | : In Stock |
Pretomanid Impurity 13
| CAT No | : SRC-P16179 |
| CAS No | : NA |
| Mol. F | : C9H7Br2F3O |
| Mol. Wt | : 348.0 |
| INV STATUS | : In Stock |
Benzocaine-N-Beta-D-Glucoside
| CAT No | : SRC-B1469 |
| CAS No | : 28315-50-6 |
| Mol. F | : C15H21NO7 |
| Mol. Wt | : 327.3 g/mol |
| INV STATUS | : In Stock |
N-Nitroso Naratriptan
| CAT No | : SRC-N014411 |
| CAS No | : 1216880-64-6 |
| Mol. F | : C17H24N4O3S |
| Mol. Wt | : 364.5 g/mol |
| INV STATUS | : In Stock |
N-Nitroso Eletriptan
| CAT No | : SRC-N014493 |
| CAS No | : NA |
| Mol. F | : C22H25N3O3S |
| Mol. Wt | : 411.5 g/mol |
| INV STATUS | : In Stock |
N-Nitroso Zolmitriptan
| CAT No | : SRC-N014521 |
| CAS No | : NA |
| Mol. F | : C16H20N4O3 |
| Mol. Wt | : 316.4 g/mol |
| INV STATUS | : In Stock |
N-Nitroso Tadalafil
| CAT No | : SRC-N014528 |
| CAS No | : NA |
| Mol. F | : C22H18N4O5 |
| Mol. Wt | : 418.4 g/mol |
| INV STATUS | : In Stock |
Paroxetine 4-Hydroxy Metabolite
| CAT No | : SRC-P16048 |
| CAS No | : 112058-90-9 |
| Mol. F | : C19H22FNO3 |
| Mol. Wt | : 331.4 |
| INV STATUS | : In Stock |
Paroxetine 3-Hydroxy Metabolite
| CAT No | : SRC-P16049 |
| CAS No | : 112058-89-6 |
| Mol. F | : C19H22FNO3 |
| Mol. Wt | : 331.4 |
| INV STATUS | : In Stock |
N-Nitroso Rizatriptan
.png)
| CAT No | : SRC-N014974 |
| CAS No | : NA |
| Mol. F | : C15H18N6O |
| Mol. Wt | : 298.4 g/mol |
| INV STATUS | : In Stock |
N-Nitroso Orlistat
| CAT No | : SRC-N0141720 |
| CAS No | : NA |
| Mol. F | : C29H52N2O6 |
| Mol. Wt | : 524.7 g/mol |
| INV STATUS | : In Stock |
N-Nitroso Ropinirole
| CAT No | : SRC-N0141738 |
| CAS No | : NA |
| Mol. F | : C16H23N3O2 |
| Mol. Wt | : 289.4 g/mol |
| INV STATUS | : In Stock |
PET Impurity 5
| CAT No | : SRC-T20072 |
| CAS No | : 16104-98-6 |
| Mol. F | : C24H24O10 |
| Mol. Wt | : 472.45 g/mol |
| INV STATUS | : In Stock |
PET Impurity 7
| CAT No | : SRC-T20073 |
| CAS No | : 29278-57-7 |
| Mol. F | : C22H20O9 |
| Mol. Wt | : 428.39 g/mol |
| INV STATUS | : In Stock |
PET Impurity 3 | ETHYLENE TEREPHTHALATE CYCLIC TETRAMER
| CAT No | : SRC-T20074 |
| CAS No | : 16104-96-4 |
| Mol. F | : C40H32O16 |
| Mol. Wt | : 768.68 g/mol |
| INV STATUS | : In Stock |
PET Impurity 2 | Ethylene Terephthalate Cyclic Dimer
| CAT No | : SRC-T20075 |
| CAS No | : 24388-68-9 |
| Mol. F | : C20H16O8 |
| Mol. Wt | : 384.34 g/mol |
| INV STATUS | : In Stock |
PET Impurity 4 | Ethylene Terephthalate Cyclic Pentamer
| CAT No | : SRC-T20076 |
| CAS No | : 16104-97-5 |
| Mol. F | : C50H40O20 |
| Mol. Wt | : 960.85 g/mol |
| INV STATUS | : In Stock |
PET Impurity 1 | Ethylene terephthalate cyclic trimer
| CAT No | : SRC-T20077 |
| CAS No | : 7441-32-9 |
| Mol. F | : C30H24O12 |
| Mol. Wt | : 576.50 g/mol |
| INV STATUS | : In Stock |
Fluvastatin
| CAT No | : SRC-F6621 |
| CAS No | : 93957-54-1 |
| Mol. F | : C24H25FNO4 : Na |
| Mol. Wt | : 410.5 : 23.0g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin EP Impurity A Sodium Salt
| CAT No | : SRC-F6622 |
| CAS No | : 174956-43-5 |
| Mol. F | : C24H25FNO4 : Na |
| Mol. Wt | : 410.5 : 23.0g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin EP Impurity B
| CAT No | : SRC-F6623 |
| CAS No | : 194934-96-8 |
| Mol. F | : C28H34FNO4 |
| Mol. Wt | : 467.6g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin EP Impurity C Sodium salt
| CAT No | : SRC-F6624 |
| CAS No | : 2451176-31-9 |
| Mol. F | : C23H23FNO4 : Na |
| Mol. Wt | : 396.4 : 23.0g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Sodium EP Impurity D
| CAT No | : SRC-F6625 |
| CAS No | : 1160169-39-0 |
| Mol. F | : C24H24FNO4 : Na |
| Mol. Wt | : 409.5 : 23.0g/mole |
| INV STATUS | : In Stock |
Fluvastatin EP Impurity E
| CAT No | : SRC-F6626 |
| CAS No | : NA |
| Mol. F | : C24H22FNO3 |
| Mol. Wt | : 391.4g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Sodium EP Impurity F
| CAT No | : SRC-F6627 |
| CAS No | : 2118370-50-4 |
| Mol. F | : C24H23FNO3 : Na |
| Mol. Wt | : 392.5 : 23.0g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin EP Impurity G
| CAT No | : SRC-F6628 |
| CAS No | : 101125-34-2 |
| Mol. F | : C18H16FNO |
| Mol. Wt | : 281.3g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin USP Related Compound B
| CAT No | : SRC-F6629 |
| CAS No | : 129332-29-2 |
| Mol. F | : C28H34FNO4 |
| Mol. Wt | : 467.6g/mole |
| INV STATUS | : Custom Synthesis |
(3R,5S)-Fluvastatin-3,5-Acetonide Tert-Butyl Ester
| CAT No | : SRC-F6630 |
| CAS No | : 500731-91-9 |
| Mol. F | : C31H38FNO4 |
| Mol. Wt | : 507.6g/mole |
| INV STATUS | : Custom Synthesis |
(3S,5S,6E)-O-tert-Butyl Fluvastatin
| CAT No | : SRC-F6631 |
| CAS No | : 194935-00-7 |
| Mol. F | : C28H34FNO4 |
| Mol. Wt | : 467.6g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Ethyl Ester
| CAT No | : SRC-F6632 |
| CAS No | : 615263-37-1 |
| Mol. F | : C26H30FNO4 |
| Mol. Wt | : 439.5g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Lactone
| CAT No | : SRC-F6633 |
| CAS No | : NA |
| Mol. F | : C24H24FNO3 |
| Mol. Wt | : 393.5g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Methyl Ester
| CAT No | : SRC-F6634 |
| CAS No | : 786710-21-2 |
| Mol. F | : C25H28FNO4 |
| Mol. Wt | : 425.5g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Methyl Impurity
| CAT No | : SRC-F6635 |
| CAS No | : 1025085-42-0 |
| Mol. F | : C18H18FN |
| Mol. Wt | : 267.3g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Z-Isomer Tert-Butyl Ester
| CAT No | : SRC-F6636 |
| CAS No | : NA |
| Mol. F | : C28H34FNO4 |
| Mol. Wt | : 467.6g/mole |
| INV STATUS | : Custom Synthesis |
(3R,5S)-Fluvastatin Sodium Salt
| CAT No | : SRC-F6637 |
| CAS No | : 155229-75-7 |
| Mol. F | : C24H25FNO4 : Na |
| Mol. Wt | : 410.4 : 23.0g/mole |
| INV STATUS | : Custom Synthesis |
(3S,5R)-Fluvastatin Sodium Salt
| CAT No | : SRC-F6638 |
| CAS No | : 155229-76-8 |
| Mol. F | : C24H26FNO4 : Na |
| Mol. Wt | : 411.5 : 23.0g/mole |
| INV STATUS | : Custom Synthesis |
(3S,5S)-Fluvastatin Sodium Salt
| CAT No | : SRC-F6639 |
| CAS No | : 789471-33-6 |
| Mol. F | : C24H25FNO4 : Na |
| Mol. Wt | : 410.4 : 23.0g/mole |
| INV STATUS | : Custom Synthesis |
3-Keto Fluvastatin Sodium Salt
| CAT No | : SRC-F6640 |
| CAS No | : 1331822-02-6 |
| Mol. F | : C24H24FNO4 : Na |
| Mol. Wt | : 409.5 : 23.0g/mole |
| INV STATUS | : Custom Synthesis |
5-Hydroxy Fluvastatin
| CAT No | : SRC-F6641 |
| CAS No | : 174874-46-5 |
| Mol. F | : C24H26FNO5 |
| Mol. Wt | : 427.5g/mole |
| INV STATUS | : Custom Synthesis |
6-Hydroxy Fluvastatin
| CAT No | : SRC-F6642 |
| CAS No | : 174874-47-6 |
| Mol. F | : C24H26FNO5 |
| Mol. Wt | : 427.5g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Ethyl Boronate Ester
| CAT No | : SRC-F6643 |
| CAS No | : 927436-37-1 |
| Mol. F | : C30H37BFNO4 |
| Mol. Wt | : 505.4g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin lactone S-Isomer
| CAT No | : SRC-F6644 |
| CAS No | : NA |
| Mol. F | : C24H21FNO3 : Na |
| Mol. Wt | : 390.4 : 23.0g/mole |
| INV STATUS | : Custom Synthesis |
N-Deisopropyl Fluvastatin
| CAT No | : SRC-F6645 |
| CAS No | : NA |
| Mol. F | : C21H20FNO4 |
| Mol. Wt | : 369.4g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Impurity 2
| CAT No | : SRC-F6646 |
| CAS No | : 1656262-10-0 |
| Mol. F | : C24H22FNO2 |
| Mol. Wt | : 375.4g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Impurity 4
| CAT No | : SRC-F6647 |
| CAS No | : 2756441-34-4 |
| Mol. F | : C27H30FNO4 |
| Mol. Wt | : 451.5g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Impurity 5
| CAT No | : SRC-F6648 |
| CAS No | : 920275-09-8 |
| Mol. F | : C23H24FNO2 |
| Mol. Wt | : 365.4g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Impurity 6
| CAT No | : SRC-F6649 |
| CAS No | : 113240-51-0 |
| Mol. F | : C18H18FNO |
| Mol. Wt | : 283.3g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Impurity 7
| CAT No | : SRC-F6650 |
| CAS No | : 477740-24-2 |
| Mol. F | : C25H24FNO2 |
| Mol. Wt | : 389.5g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Impurity 8
| CAT No | : SRC-F6651 |
| CAS No | : NA |
| Mol. F | : C20H18FNO |
| Mol. Wt | : 307.4g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Impurity 9
| CAT No | : SRC-F6652 |
| CAS No | : NA |
| Mol. F | : C20H18FNO |
| Mol. Wt | : 307.4g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Impurity 10
| CAT No | : SRC-F6653 |
| CAS No | : NA |
| Mol. F | : C24H26FNO4 |
| Mol. Wt | : 411.5g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Impurity 11
| CAT No | : SRC-F6654 |
| CAS No | : NA |
| Mol. F | : C24H26FNO4 |
| Mol. Wt | : 411.5g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Impurity 12
| CAT No | : SRC-F6655 |
| CAS No | : NA |
| Mol. F | : C28H32FNO4 |
| Mol. Wt | : 465.6g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Impurity 13
| CAT No | : SRC-F6656 |
| CAS No | : NA |
| Mol. F | : C28H32FNO4 |
| Mol. Wt | : 465.6g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Impurity 14
| CAT No | : SRC-F6657 |
| CAS No | : 2396616-38-7 |
| Mol. F | : C23H22FNO |
| Mol. Wt | : 347.4g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Impurity 15
| CAT No | : SRC-F6658 |
| CAS No | : 920275-08-7 |
| Mol. F | : C28H30FNO3 |
| Mol. Wt | : 447.6g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Impurity 16
| CAT No | : SRC-F6659 |
| CAS No | : 145797-78-0 |
| Mol. F | : C20H20FNO |
| Mol. Wt | : 309.4g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Impurity 17
| CAT No | : SRC-F6660 |
| CAS No | : 93937-37-2 |
| Mol. F | : C19H16FNO |
| Mol. Wt | : 293.3g/mole |
| INV STATUS | : Custom Synthesis |
Fluvastatin Impurity 18
| CAT No | : SRC-F6661 |
| CAS No | : 2117644-62-7 |
| Mol. F | : C24H26FNO4 |
| Mol. Wt | : 411.5g/mole |
| INV STATUS | : Custom Synthesis |
OUR PURPOSE
Driven by Science, Backed by Experience | Delivering Reliable Research Solutions.
OUR PROCESS
End-to-end support in molecule design, synthesis, and analysis
Strategic partnerships with global pharma and biotech companies
Proven expertise in compliance, quality, and scalable delivery. Investors
OUR PROCESS
Our Services
Expertise at Synchemia
Deuterated Standards
Analytical Services
API Impurities
FT Projects
Nitrosamine Impurities
Process Development
Peptide Synthesis
Deuterated Standards
With decades of expertise, Synchemia partners with global pharma and biotech companies to accelerate research, development, and production with precision.
Know More
Why choose us
Providing Excellence and Expertise in Every Solution
Operate efficiency
Efficient project management combined with strong quality systems ensures reproducible results, regulatory readiness, and optimized timelines.Smart processes. Faster turnaround. Reliable outcomes.
Expertise across services
Our multidisciplinary expertise spans impurity synthesis, analytical support, and complex chemical development to meet diverse research and regulatory needs.
Custom solutions
We provide tailor-made scientific solutions designed to address complex and unique research challenges, from route scouting to final impurity or reference standard delivery.
Impact
Backed by decades of expertise
"Backed by decades of expertise, Synchemia serves as a strategic extension of your R&D team. We don’t just deliver molecules; we deliver the precision and innovation that global Pharmacutical, Cosmetic and biotech Industry demands."
15000+
Complex molecules synthesized successfully
200+
Global Pharmacutical and Biotech clients served
100+
Countries reached through our collaborations
All products and services provided by Synchemia are intended for laboratory research and development use only and Not for Human Consumption. They are not intended for human clinical use or direct therapeutic application.
Accreditions
×
![]()